Post-transfer editing by a eukaryotic leucyl-tRNA synthetase resistant to the broad-spectrum drug AN2690.
about
Peripheral insertion modulates the editing activity of the isolated CP1 domain of leucyl-tRNA synthetaseDegenerate connective polypeptide 1 (CP1) domain from human mitochondrial leucyl-tRNA synthetase.The Yin and Yang of tRNA: proper binding of acceptor end determines the catalytic balance of editing and aminoacylation.Aminoacylation and translational quality control strategy employed by leucyl-tRNA synthetase from a human pathogen with genetic code ambiguityCoexistence of bacterial leucyl-tRNA synthetases with archaeal tRNA binding domains that distinguish tRNA(Leu) in the archaeal mode.Transfer RNA: a dancer between charging and mis-charging for protein biosynthesis.
P2860
Post-transfer editing by a eukaryotic leucyl-tRNA synthetase resistant to the broad-spectrum drug AN2690.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Post-transfer editing by a euk ...... he broad-spectrum drug AN2690.
@en
Post-transfer editing by a euk ...... he broad-spectrum drug AN2690.
@nl
type
label
Post-transfer editing by a euk ...... he broad-spectrum drug AN2690.
@en
Post-transfer editing by a euk ...... he broad-spectrum drug AN2690.
@nl
prefLabel
Post-transfer editing by a euk ...... he broad-spectrum drug AN2690.
@en
Post-transfer editing by a euk ...... he broad-spectrum drug AN2690.
@nl
P2093
P2860
P356
P1433
P1476
Post-transfer editing by a euk ...... he broad-spectrum drug AN2690.
@en
P2093
En-Duo Wang
Xiao-Long Zhou
P2860
P304
P356
10.1042/BJ20100474
P407
P577
2010-09-01T00:00:00Z